Related references
Note: Only part of the references are listed.Phase I Safety and Immunogenicity Trial of Plasmodium vivax CS Derived Long Synthetic Peptides Adjuvanted with Montanide ISA 720 or Montanide ISA 51
Socrates Herrera et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
Simon J. Draper et al.
JOURNAL OF IMMUNOLOGY (2010)
A Single Immunization with CoVaccine HT-Adjuvanted H5N1 Influenza Virus Vaccine Induces Protective Cellular and Humoral Immune Responses in Ferrets
R. Bodewes et al.
JOURNAL OF VIROLOGY (2010)
Immunization with Cocktail of HIV-Derived Peptides in Montanide ISA-51 Is Immunogenic, but Causes Sterile Abscesses and Unacceptable Reactogenicity
Barney S. Graham et al.
PLOS ONE (2010)
Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response
Kwadwo A. Kusi et al.
PLOS ONE (2010)
Immunogenicity and some safety features of a VEGF-based cancer therapeutic vaccine in rats, rabbits and non-human primates
Yanelys Morera et al.
VACCINE (2010)
Feasibility of single-shot H5N1 influenza vaccine in ferrets, macaques and rabbits
J. G. M. Heldens et al.
VACCINE (2010)
Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity
Kwadwo A. Kusi et al.
PLOS ONE (2009)
High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model
Sheetij Dutta et al.
PLOS ONE (2009)
Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum
David E. Arnot et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission
Catherine S. M. Diefenbach et al.
CLINICAL CANCER RESEARCH (2008)
A diversity-covering approach to immunization with Plasmodium falciparum apical membrane antigen 1 induces broader allelic recognition and growth inhibition responses in rabbits
Edmond J. Remarque et al.
INFECTION AND IMMUNITY (2008)
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
Yimin Wu et al.
PLOS ONE (2008)
Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses
Jeffrey A. Lyon et al.
PLOS ONE (2008)
Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1
Bart W. Faber et al.
INFECTION AND IMMUNITY (2007)
Immunity to recombinant Plasmodium falciparum merozoite surface protein 1 (MSP1):: Protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity
Sanjay Singh et al.
INFECTION AND IMMUNITY (2006)
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel®, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide
GED Mullen et al.
VACCINE (2006)
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques
JAM Langermans et al.
VACCINE (2005)
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites
O Silvie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells
GH Mitchell et al.
INFECTION AND IMMUNITY (2004)
Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites
S Dutta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development
LH Bannister et al.
JOURNAL OF CELL SCIENCE (2003)
Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1
JM Burns et al.
VACCINE (2003)
Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes
VK Goel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Effects of the anaesthetic/tranquillizer treatments on selected plasma biochemical parameters in NZW rabbits
AG Gil et al.
LABORATORY ANIMALS (2003)
Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria
AW Stowers et al.
INFECTION AND IMMUNITY (2002)
In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1):: Production and activity of an AMA1 vaccine and generation of a multiallelic response
MC Kennedy et al.
INFECTION AND IMMUNITY (2002)
Independent translocation of two micronemal proteins in developing Plasmodium falciparum merozoites
J Healer et al.
INFECTION AND IMMUNITY (2002)
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli
S Dutta et al.
INFECTION AND IMMUNITY (2002)
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1
SA Howell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Specificity of the protective antibody response to apical membrane antigen 1
AN Hodder et al.
INFECTION AND IMMUNITY (2001)
Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species
T Triglia et al.
MOLECULAR MICROBIOLOGY (2000)
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection
DL Narum et al.
INFECTION AND IMMUNITY (2000)
Functional conservation of the malaria vaccine antigen MSP-1(19) across distantly related Plasmodium species
RA O'Donnell et al.
NATURE MEDICINE (2000)
Share Paper
